General Information of the Compound
| Compound ID |
CP0866750
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[2-(2-{2-[2-Diallylamino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-propionylamino)-3-(4-isothiocyanato-phenyl)-propionylamino]-4-methyl-pentanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H48N6O7S
|
||||||||||||||||||
| Molecular Weight |
720.893
|
||||||||||||||||||
| Canonical SMILES |
C=CCN(CC=C)[C@@H](Cc1ccc(O)cc1)C(=O)NC(C)C(=O)NC(C)C(=O)N[C@@H](Cc1ccc(N=C=S)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H48N6O7S/c1-7-17-43(18-8-2)32(21-27-11-15-29(44)16-12-27)36(48)40-24(5)33(45)39-25(6)34(46)41-30(20-26-9-13-28(14-10-26)38-22-51)35(47)42-31(37(49)50)19-23(3)4/h7-16,23-25,30-32,44H,1-2,17-21H2,3-6H3,(H,39,45)(H,40,48)(H,41,46)(H,42,47)(H,49,50)/t24?,25?,30-,31-,32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DCRGSBYKTHQNSB-USBLYKAKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT01526, Delta-type opioid receptor